In some cancer cell lines, the gene encoding activin A (inhibin βA [INHBA]) is over-expressed and enhances cancer proliferation. Protein levels of activin A and follistatin were assessed in glioblastoma and normal brain tissues in this study, and the effect of activin A and follistatin treatment on the proliferation of U87 human glioblastoma cells in vitro was also studied. High levels of activin A were observed in glioblastomas compared with normal brain tissue. In contrast, follistatin levels were similar between the two tissues. [3H]Thymidine assay showed that activin A (3–30 ng/ml) produced a dose-dependent increase in DNA synthesis of U87 cells compared with controls. Flow cytometric analyses showed that activin A increased the proliferative index of U87 cells compared with controls. Activin A also induced up-regulation of p-SMAD2/3 in a dose-dependent manner. Treatment of U87 cells with follistatin blocked these activin A-induced effects. The disequilibrium between activin A and follistatin may play a role in the development of glioblastoma.
CounsellCEGrantR: Incidence studies of primary and secondary intracranial tumors: A systematic review of their methodology and results. J Neurooncol1998; 37: 241–250.
2.
PobereskinLHChadduckJB: Incidence of brain tumours in two English counties: A population based study. J Neurol Neurosurg Psychiatry2000; 69: 464–471.
3.
WrenschMMinnYChewT: Epidemiology of primary brain tumors: Current concepts and review of the literature. Neuro Oncol2002; 4: 278–299.
4.
CastroMGCowenRWilliamsonIK: Current and future strategies for the treatment of malignant brain tumors. Pharmacol Ther2003; 98: 71–108.
5.
Wild-BodeCWellerMWickW: Molecular determinants of glioma cell migration and invasion. J Neurosurg2001; 94: 978–984.
JenningsMTPietenpolJA: The role of transforming growth factor beta in glioma progression. J Neurooncol1998; 36: 123–140.
8.
KnightPGGlisterC: TGF-β superfamily members and ovarian follicle development. Reproduction2006; 132: 191–206.
9.
YingSY: Inhibins, activins, and follistatins: Gonadal proteins modulating the secretion of follicle-stimulating hormone. Endocr Rev1988; 9: 267–293.
10.
ThatcherJD: The TGF-β signal transduction pathway. Sci Signal2010; 3: tr4.
11.
FrieseMAWischhusenJWickW: RNA interference targeting transforming growth factor-beta enhances NKG2D-mediated antiglioma immune response, inhibits glioma cell migration and invasiveness, and abrogates tumorigenicity in vivo. Cancer Res2004; 64: 7596–7603.
12.
WildiSKleeffJMaruyamaH: Overexpression of activin A in stage IV colorectal cancer. Gut2001; 49: 409–417.
13.
ShimonakaMInouyeSShimasakiS: Follistatin binds to both activin and inhibin through the common subunit. Endocrinology1991; 128: 3313–3315.
14.
NakamuraTTakioKEtoY: Activinbinding protein from rat ovary is follistatin. Science1990; 247: 836–838.
15.
ShimasakiSKogaMEschF: Structure of the human follistatin precursor and its genomic organization. Proc Natl Acad Sci USA1988; 85: 4218–4222.
16.
SchneyerALRzucidloDASlussPM: Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. Endocrinology1994; 135: 667–674.
17.
CrissmanHAHironsGT: Staining of DNA in live and fixed cells. Methods Cell Biol1994; 41: 195–209.
18.
ValeWRivierJVaughanJ: Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature1986; 321: 776–779.
19.
LingNYingSYUenoN: Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin. Nature1986; 321: 779–782.
20.
FindlayJK: An update on the roles of inhibin, activin, and follistatin as local regulators of folliculogenesis. Biol Reprod1993; 48: 15–23.
21.
KojimaIOgataE: Dual effect of activin A on cell growth in Balb/c 3T3 cells. Biochem Biophys Res Commun1989; 159: 1107–1113.
22.
RabinoviciJSpencerSJJaffeRB: Recombinant human activin-A promotes proliferation of human luteinized preovulatory granulosa cells in vitro. J Clin Endocrinol Metab1990; 71: 1396–1398.
23.
Di SimoneNCrowleyWFJrWangQF: Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: A potential role in autocrine growth regulation. Endocrinology1996; 137: 486–494.
24.
LiuQYNiranjanBGomesP: Inhibitory effects of activin on the growth and morphogenesis of primary and transformed mammary epithelial cells. Cancer Res1996; 56: 1155–1163.
25.
KanamaruCYasudaHTakedaM: Smad7 is induced by norepinephrine and protects rat hepatocytes from activin A-induced growth inhibition. J Biol Chem2001; 276: 45636–45641.
26.
ZhangZZhaoYBatresY: Regulation of growth and prostatic marker expression by activin A in an androgen-sensitive prostate cancer cell line LNCAP. Biochem Biophys Res Commun1997; 234: 362–365.
27.
SuginoHNakamuraTHasegawaY: Erythroid differentiation factor can modulate follicular granulosa cell functions. Biochem Biophys Res Commun1988; 153: 281–288.
28.
YoshinagaKYamashitaKMimoriK: Activin A causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. Ann Surg Oncol2008; 15: 96–103.
29.
MathewsLS: Activin receptors and cellular signaling by the receptor serine kinase family. Endocr Rev1994; 15: 310–325.
30.
WilliamsTMWilliamsMEHeatonJH: Group 13 HOX proteins interact with the MH2 domain of R-Smads and modulate Smad transcriptional activation functions independent of HOX DNA-binding capability. Nucleic Acids Res2005; 33: 4475–4484.
31.
OginoHYanoSKakiuchiS: Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin Cancer Res2008; 14: 660–667.
